Akers Biosciences (AKER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKER | NEPH | VERU | ||
| Company | Akers Biosciences | Nephros Inc | Veru Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.65 | 5.10 | 2.30 | ||
| High | 3.04 | 5.32 | 2.35 | ||
| Low | 2.40 | 4.96 | 2.22 | ||
| Latest | 2.47 | 5.03 | 2.32 | ||
| Change | -0.26 | -0.04 | +0.06 | ||
| % Change | -9.52% | -0.79% | +2.65% | ||
| Volume | 1,583,500 | 140,000 | 266,800 | ||
| 20-Day Average Volume | 346,100 | 67,955 | 164,630 | ||
| Previous Close | 2.73 | 5.07 | 2.26 | ||
| Industry | Medical Products | Medical Products | Medical Products | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.18 | 5.16 | 2.42 | ||
| 20-Day Raw Stochastic | 3.89% | 29.44% | 34.48% | ||
| 20-Day Relative Strength | 40.31 | 49.68 | 39.04 | ||
| Weighted Alpha | -14.85 | +154.15 | -51.22 | ||
| Today's Opinion | 24% Sell | 72% Buy | 100% Sell | ||
| Previous Opinion | 8% Sell | 72% Buy | 100% Sell | ||
| Last Month's Opinion | 72% Buy | 80% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -23.05% since 04/09/21 | +0.20% since 12/12/25 | -4.13% since 12/12/25 | ||
| Low | 2.40 on 04/16/21 | 4.80 on 12/16/25 | 2.17 on 12/17/25 | ||
| High | 3.60 on 04/12/21 | 5.32 on 12/19/25 | 2.60 on 12/17/25 | ||
| 1-Month | |||||
| %Chg | -32.70% since 03/16/21 | unch since 11/19/25 | -2.93% since 11/19/25 | ||
| Low | 2.40 on 04/16/21 | 4.45 on 12/08/25 | 2.11 on 11/20/25 | ||
| High | 4.09 on 03/19/21 | 6.42 on 11/26/25 | 2.70 on 12/09/25 | ||
| 3-Month | |||||
| %Chg | -6.79% since 01/15/21 | +20.33% since 09/19/25 | -33.14% since 09/19/25 | ||
| Low | 2.40 on 04/16/21 | 3.66 on 11/10/25 | 2.11 on 11/20/25 | ||
| High | 5.24 on 02/16/21 | 6.42 on 11/26/25 | 4.59 on 10/08/25 | ||
| 6-Month | |||||
| %Chg | +8.81% since 10/16/20 | +40.50% since 06/18/25 | -61.59% since 06/18/25 | ||
| Low | 1.65 on 11/11/20 | 2.89 on 08/07/25 | 2.11 on 11/20/25 | ||
| High | 5.24 on 02/16/21 | 6.42 on 11/26/25 | 7.25 on 06/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 41,133 | 53,454 | 37,236 | ||
| Shares Outstanding, K | 16,653 | 10,627 | 16,050 | ||
| Annual Sales | 0 | 14,160,000 | 16,890,000 | ||
| Annual Net Income | -17,580,000 | 70,000 | -37,800,000 | ||
| Last Quarter Sales | 0 | 4,760,000 | 0 | ||
| Last Quarter Net Income | -3,286,745 | 340,000 | -7,330,000 | ||
| 60-Month Beta | 0.33 | 1.48 | -1.01 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.03 on 11/06/25 | -0.50 on 08/12/25 | ||
| Latest Earnings Date | 05/21/21 | 03/23/26 | 02/12/26 | ||
| Most Recent Dividend | N/A | N/A | 0.070 on 04/28/14 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 38.69 | 0.00 | ||